期刊文献+

Chemical approaches towards installation of rare functional groups in bacterial surface glycans

原文传递
导出
摘要 Bacterial surface glycans perform a diverse and important set of biological roles,and have been widely used in the treatment of bacterial infectious diseases.The majority of bacterial surface glycans are decorated with diverse rare functional groups,including amido,acetamidino,carboxamido and pyruvate groups.These functional groups are thought to be important constituents for the biological activities of glycans.Chemical synthesis of glycans bearing these functional groups or their variants is essential for the investigation of structure-activity relationships by a medicinal chemistry approach.To date,a broad choice of synthetic methods is available for targeting the different rare functional groups in bacterial surface glycans.This article reviews the structures of naturally occurring rare functional groups in bacterial surface glycans,and the chemical methods used for installation of these groups.
出处 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2022年第6期401-420,共20页 中国天然药物(英文版)
基金 This work was supported by the National Natural Science Foundation of China(Nos.22077052,21877052,21907039,22107037) China Postdoctoral Science Foundation(2020M681487,2021M691279) the National Key R&D Program of China(2020YFA0908304) the Natural Science Foundation of Jiangsu Province(BK20180030,BK20190575) the National First-class Discipline Program of Light Industry Technology and Engineering(LITE2018-14) the 111 Project(111-2-06) the Open Project of Key Laboratory of Carbohydrate Chemistry and Biotechnology(Jiangnan University),Ministry of Education(KLCCB-KF202005).
  • 相关文献

参考文献6

二级参考文献89

  • 1Adams EW, Ratner DM, Bokesch HR, McMahon JB, O'Keefe BR, Seeberger PH. 2004. Oligosaccharide and glycoprotein mi- croarrays as tools in HIV glycobiology; glycan-dependent gpl20/protein interactions. Chem Biol, 11: 875-881.
  • 2Alama SM, Dennisona SM, Aussedatd B, Vohrad Y, Parkd PK, Fern/mdez-Tejadad A, Stewarta S, Jaegera FH, Anastia K, Blinna JH, Keplere TB, Bonsignori M, Liao H-X, Sodroski JG, Danishefsky S J, Haynesa BF. 2013. Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. Proc Natl Acad Sci U S A, 110: 18214-18219.
  • 3Anish C, Schumann B, Pereira CL, Seeberger PH. 2014. Chemic- al biology approaches to designing defined carbohydrate vac- cines. Chem Biol, 21: 38-50.
  • 4Astronomo RD, Burton DR. 2010. Carbohydrate vaccines: devel- oping sweet solutions to sticky situations? Nat Rev Drug Dis- cov, 9: 308-324.
  • 5Astronomo RD, Kaltgrad E, Udit AK, Wang SK, Doores KJ, Huang CY, Pantophlet R, Paulson JC, Wong CH, Finn MG, Burton DR. 2010. Defining criteria for oligomannose immuno- gens for HIV using icosahedral virus capsid scaffolds. Chem Biol, 17:357- 370.
  • 6Astronomo RD, Lee HK, Scanlan CN, Pantophlet R, Huang CY, Wilson IA, Blixt O, Dwek RA, Wong CH, Burton DR. 2008. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the selfglycans ofgpl20. J Virol, 82: 6359-6368.
  • 7Blattner C, Lee JH, Sliepen K, Derking R, Falkowska E, Pefia ATdl, Cupo A, Julien J-P, Gils Mv, Lee PS, Peng W, Paulson JC, Poignard P, Burton DR, Moore JP, Sanders RW, Wilson IA,Ward AB. 2014. Structural delineation of a quaternary, cleav- age-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity, 40: 669-680.
  • 8Burton DR, Mascola JR. 2015. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol, 16: 571-576.
  • 9Cai H, Huang ZH, Shi L, Sun ZY, Zhao YF, Kunz H, Li YM. 2012. Variation of the glycosylation pattern in MUC 1 gly- copeptide BSA vaccines and its influence on the immune re- sponse. Angew Chem Int Ed Engl, 51 : 1719-1723.
  • 10Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA. 2005. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A, 102: 13372-13377.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部